Four Texas residents forever connected by two kidney donations in different cities: 'Superbly timed' Collaboration between two hospitals gave Jorge Mendez, 50, and Ann Winer, 71, a new chance at life Melissa Rudy By Melissa Rudy Fox News Published February 26, 2024 4:15am EST ++++++

Four Texas residents forever connected by two kidney donations in different cities: 'Superbly timed' Collaboration between two hospitals gave Jorge Mendez, 50, and Ann Winer, 71, a new chance at life Melissa Rudy By Melissa Rudy Fox News Published February 26, 2024 4:15am EST https://www.foxnews.com/health/four-texas-residents-connected-two-kidney-donations-different-cities-timed Was Wendy Williams’ dementia caused by alcoholism? Experts share insights Former TV talk show host allegedly battled alcoholism for years before diagnosis of frontotemporal dementia Melissa Rudy By Melissa Rudy Fox News Published February 23, 2024 5:13pm EST https://www.foxnews.com/health/wendy-williams-dementia-caused-alcoholism-experts For women over 60, here is the number of daily steps needed to protect heart health The '10,000-step rule’ may not be the benchmark for all age groups, say researchers Melissa Rudy By Melissa Rudy Fox News Published February 28, 2024 5:24am EST https://www.foxnews.com/health/women-over-60-number-daily-steps-needed-protect-heart-health Amid Florida measles outbreak, surgeon general lets parents decide whether to send unvaccinated kids to school Two doctors weighed in on controversial virus guidance to parents Melissa Rudy By Melissa Rudy Fox News Published February 23, 2024 9:00pm EST https://www.foxnews.com/health/florida-measles-outbreak-surgeon-general-lets-parents-decide-whether-send-unvaccinated-kids-school Ask a doc: ‘Why am I always thirsty — and what should I do about it?' Excessive thirst can be a sign of health issues, doctors warn By Erica Lamberg Fox News Published February 28, 2024 1:45pm EST https://www.foxnews.com/health/ask-doc-why-always-thirsty-what-do-about ‘COVID paralyzed my diaphragm’: Marathon runner shares how the infection took his breath away Tennessee athlete reveals how life-changing surgery gave him his life back Melissa Rudy By Melissa Rudy Fox News Published February 22, 2024 5:00am EST https://www.foxnews.com/health/covid-paralyzed-diaphragm-marathon-runner-shares-how-infection-took-breath-away

miércoles, 28 de febrero de 2024

Relaxation Techniques: What You Need To Know

https://www.nccih.nih.gov/health/relaxation-techniques-what-you-need-to-know?nav=govd Relaxation techniques are practices to help bring about the body’s “relaxation response,” which is the opposite of the stress response. The relaxation response is characterized by slower breathing, lower blood pressure, and a reduced heart rate. One relaxation technique, called progressive muscle relaxation, involves tensing different muscles in your body and then releasing the tension. Another technique, called guided imagery, involves picturing objects, scenes, or events that are associated with relaxation or calmness and attempting to produce a similar feeling in your body. The use of these techniques has increased in recent years. National survey data show that 6.4 percent of U.S. adults used guided imagery or progressive muscle relaxation in 2022, compared to 3.8 percent in 2002.

NIA is leading efforts to coordinate NIH palliative care research February 28, 2024

https://www.nia.nih.gov/research/blog/2024/02/nia-leading-efforts-coordinate-nih-palliative-care-research?utm_source=NIA+Main&utm_campaign=a1204d030f-blog-palliativecare-2-28-24&utm_medium=email&utm_term=0_-8180ce9847-%5BLIST_EMAIL_ID%5D Palliative care is an interdisciplinary field focused on improving quality of life for people with serious illness and their families and caregivers. Currently multiple NIH Institutes and Centers support research on palliative care, but a centralized NIH approach would help identify synergies and create a clearer training path for scientists in this area. We’re excited that recently, NIA was named the lead NIH Institute for this effort. If you’re interested in being part of this project, be sure to register for the pre-application webinar on March 15, and then apply by July 2 for a new funding opportunity to develop the Consortium for Palliative Care Research Across the Lifespan.

Antibody Reduces Allergic Reactions to Multiple Foods in NIH Trial Drug Can Help Protect Kids With Multiple Food Allergies During Accidental Exposure

https://www.niaid.nih.gov/news-events/antibody-reduces-allergic-reactions-multiple-foods-nih-trial-0?utm_campaign=+59565440&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term= An NIAID study published today in The New England Journal of Medicine found a 16-week course of omalizumab increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could eat without an allergic reaction. This Phase 3 clinical trial finding suggests the antibody therapy has the potential to protect children and adolescents if they accidentally eat a food to which they are allergic despite efforts to avoid it. The FDA approved omalizumab (Xolair) for people with food allergy on February 16 based on interim data from the NIAID trial.

ctDNA May Guide Who Needs Chemo After Colorectal Cancer Surgery

https://www.cancer.gov/news-events/cancer-currents-blog/2024/colorectal-cancer-ctdna-may-guide-adjuvant-therapy?cid=eb_govdel After surgery for colorectal cancer that’s started to spread beyond its initial location, many people go straight to treatment with chemotherapy. The idea behind this postsurgery, or adjuvant, treatment is to reduce the likelihood that the cancer will come back in other places in the body, resulting in more people being cured of the cancer.

Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies

https://www.cancer.gov/news-events/cancer-currents-blog/2024/liquid-biopsy-increase-ctdna-in-blood?cid=eb_govdel Using two different techniques, researchers showed they could temporarily boost ctDNA levels in the blood of mice with tumors. With more ctDNA in collected blood draws, a liquid biopsy could better detect cancer, the research team found.

A Potential New Way to Prevent Noise-Induced Hearing Loss: Trapping Excess Zinc Posted on February 22nd, 2024 by Dr. Monica M. Bertagnolli

https://directorsblog.nih.gov/2024/02/22/a-potential-new-way-to-prevent-noise-induced-hearing-loss-trapping-excess-zinc/ Hearing loss is a pervasive problem, affecting one in eight people aged 12 and up in the U.S. While hearing loss has multiple causes, an important one for millions of people is exposure to loud noises, which can lead to gradual hearing loss, or people can lose their hearing all at once. The only methods used to prevent noise-induced hearing loss today are avoiding loud noises altogether or wearing earplugs or other protective devices during loud activities. But findings from an intriguing new NIH-supported study exploring the underlying causes of this form of hearing loss suggest it may be possible to protect hearing in a different way: with treatments targeting excess and damaging levels of zinc in the inner ear.

Let’s Talk About It: Eating Disorders, Stigma, and Empowered Recovery Fecha y hora29 feb 2024 03:00 p. m.

https://www.zoomgov.com/webinar/register/WN_gEXa-sUvQxCiPr3HW6GHoA?utm_medium=email&utm_source=govdelivery#/registration February 29th, from 1 – 3 P.M. ET for our 2024 National Eating Disorders Awareness Week (NEDAW) webinar highlighting the latest data, disparities for underserved and underrepresented populations, and best practices in providing quality care for diverse communities. Attendees will hear from subject matter experts in the field and individuals with lived experience as they dive into the latest eating disorder considerations for individuals, loved ones, and healthcare professionals. This webinar is free and open to the public. OWH is honored to share that the Assistant Secretary for Health, Admiral Rachel L. Levine, will provide opening remarks at the event and welcome participants to this important discussion.

a todos los que me siguen... a todos los que me leen... a todos los que me buscan... a todos...

A TODOS: el día 16 de febrero, luego de una brutal tormenta, se cortó internet, se cortaron las líneas telefónicas, por ende no hubo Wi-Fi, ni conexiones de ninguna índole… me llevó dos días entender dónde estaba el problema, ya que muchos vecinos del barrio, estaban en las mismas condiciones… acudí a Telecom Personal y también lo hice a Personal Telecom, ya que no sé dónde comienza una empresa y donde termina la otra… te ofrecen un teléfono que te indica que tienes que marcar 1, o bien, marcar 2, o bien, marcar 3, o bien marcar 4, o bien, marcar 5, o bien marcar 6, pero en algún momento serás atendido por alguien, a quien jamás verás… luego de variar por la escala, alguien atendió… dijo que el cable que conecta al barrio es viejo… dijo que ahora hay una novedosa fibra óptica, que curiosamente, también es un cable, pero nuevo… dijo que el costo del cambio era importante… dijo que había que consultar al servicio técnico… dijo muchas cosas que no recuerdo, porque fueron demasiadas… dijo que tal vez el día 27 de febrero harían una visita para ver de qué se trata… dijo que el costo actual era escaso y que al ser todo nuevo, debía aumentar, casi al doble, poco más, seguramente… dijo que había beneficios suculentos, y otros no tanto… dijo, y también dijo, y volvió a repetir, por si no se entendió… a nadie le importó que no hubiese servicio durante largos días… según dijeron, todo se compensa en la factura, lo cual está por verse… como sea, los días pasan y no hay teléfono, no hay internet, no hay Wi-Fi, no hay conexión alguna… los blog´s han quedado inaccesibles, sin actualizar, pero a nadie le importa… no me he tomado vacaciones porque no hay dónde ir, ya que la mayoría de las rutas están cortadas, por lluvias recurrentes y tormentas consecuentes… tampoco he salido de la casa porque la misma no puede quedar sola, ya que hay vigías que marcan la casa, y luego roban, sin que nadie haga nada… además, una casa sola es pasible de ser ocupada por indeseables asociados al poder del narcotráfico, que es socio del poder político… el estado dejó de existir hace dos meses y medio, gracias a la nueva administración anarcocapitalista, es decir, primero instala la anarquía donde antes hubo un estado de derecho, luego habla de capitalismo para los amigos del poder, que se apoderan de todo y someten a los mortales a sus designios… en definitiva, nos hemos quedado sin país, ya que cada uno está librado a su suerte… no hay garantías constitucionales… no hay a quien quejarse… no hay a quien reclamar (por nada)… no hay derechos ni humanos ni ciudadanos… la legislatura ha dejado de existir, porque muchos se han vendido a la nueva administración… mientras tanto, la justicia tampoco existe porque es inaccesible… y en el poder ejecutivo se ha instalado la demencia… la sociedad argentina está sucumbiendo a la estupidez humana de la clase política reinante… dentro de poco tiempo, nuestro país, pasará a ser una entelequia… por favor, tenelo en cuenta, porque no sé qué será de nosotros… el editor… PD: y esto recién comienza… lo de internet es sólo una muestra… PD2: gracias al equipo técnico de Telecom Personal… es necesario agradecer a los mortales que trabajan, como lo hizo uno…

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge https://www.niaid.nih.gov/clinical-trials/laboratory-malaria-immunology-and-vaccinology-lmiv-screening-protocol?utm_campaign=+59409382&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term= Healthy volunteers needed for malaria studies Healthy volunteers are needed for malaria studies. Malaria is a disease that impacts people in many areas of the world. According to the World Health Organization, a child dies from malaria every two minutes. A safe and highly effective malaria vaccine is needed to prevent malaria-related deaths. Researchers at the Laboratory of Malaria Immunology and Vaccinology are seeking healthy volunteers for future malaria trials and vaccine studies. You may be able to participate if you: Are 18 to 50 years old Reside in the Washington D.C. metropolitan area Are not currently pregnant or breastfeeding Are interested in enrolling in a future vaccine study or malaria trial Study visits will take place at the NIH Clinical Center in Bethesda, Maryland. Compensation will be provided. For more information contact the Laboratory of Malaria Immunology and Vaccinology (LMIV) Clinical Team. Link: https://www.niaid.nih.gov/clinical-trials/laboratory-malaria-immunology-and-vaccinology-lmiv-screening-protocol Email: LMIVClinicalTrial@mail.nih.gov

Join us March 22 for a webinar on building more inclusive Alzheimer’s studies February 14, 2024

https://www.nia.nih.gov/research/blog/2024/02/join-us-march-22-webinar-building-more-inclusive-alzheimers-studies?utm_source=NIA+Main&utm_campaign=c006c663d8-blog-inclusiveADstudies-2-14-24&utm_medium=email&utm_term=0_-8180ce9847-%5BLIST_EMAIL_ID%5D NIA continues to combat health disparities in aging research. As part of our ongoing work in this area, we support scientific teams focused on improving diversity, inclusion, and engagement of populations historically underrepresented in research. If you are seeking to increase diversity and inclusion in dementia research, be sure to register for the March 22 webinar. The event will highlight successful strategies from two NIA-funded teams that can be applied to other research recruitment, diversity, and retention efforts.

Should the CDC drop its 5-day COVID isolation guidelines? Doctors weigh in As some claim the agency is considering a change in guidance, doctors call for a focus on symptoms over timetables Melissa Rudy By Melissa Rudy Fox News Published February 15, 2024 6:10am EST

Should the CDC drop its 5-day COVID isolation guidelines? Doctors weigh in As some claim the agency is considering a change in guidance, doctors call for a focus on symptoms over timetables Melissa Rudy By Melissa Rudy Fox News Published February 15, 2024 6:10am EST https://www.foxnews.com/health/should-cdc-drop-5-day-covid-isolation-guidelines-doctors-weigh-in

Ketamine therapy shown effective in treating severe depression in veterans, study finds Fifteen percent of recipients went into full remission after six weeks, according to the University of Michigan Angelica Stabile By Angelica Stabile Fox News Published February 10, 2024 8:46am EST

Ketamine therapy shown effective in treating severe depression in veterans, study finds Fifteen percent of recipients went into full remission after six weeks, according to the University of Michigan Angelica Stabile By Angelica Stabile Fox News Published February 10, 2024 8:46am EST https://www.foxnews.com/health/ketamine-therapy-effective-treating-severe-depression-veterans-study

What is Alaskapox? First fatality reported from animal-borne virus, likely contracted from stray cat Alaskapox typically only causes mild symptoms, but it can be dangerous for the immunocompromised Melissa Rudy By Melissa Rudy Fox News Published February 12, 2024 9:50pm EST | Updated February 14, 2024 12:30pm EST

What is Alaskapox? First fatality reported from animal-borne virus, likely contracted from stray cat Alaskapox typically only causes mild symptoms, but it can be dangerous for the immunocompromised Melissa Rudy By Melissa Rudy Fox News Published February 12, 2024 9:50pm EST | Updated February 14, 2024 12:30pm EST https://www.foxnews.com/health/alaska-man-dies-novel-animal-borne-virus-likely-contracted-stray-cat

miércoles, 14 de febrero de 2024

Meet the NCI Director Live

Tune in for an interactive conversation to get to know new NCI Director, Dr. Kimryn Rathmell, and hear her answers to some of your questions about the future of cancer research. Live Q&A on February 22nd at 11:30 a.m. EST on YouTube/LinkedIn/Facebook.

Ocean currents moving heat are growing closer to collapse, study says Experts say lack of heat circulation is likely to lead to a climate catastrophe spelling long and extremely cold winters in various parts of the world Associated Press|

Ocean currents moving heat are growing closer to collapse, study says Experts say lack of heat circulation is likely to lead to a climate catastrophe spelling long and extremely cold winters in various parts of the world Associated Press| https://www.ynetnews.com/health_science/article/sk55zs8st

Health Ministry calls on Israelis to get vaccinated as measles cases surge 18 cases diagnosed in Israel In past three months, majority not fully vaccinated; ministry recommends travelers abroad ensure they are vaccinated with two doses Adir Yanko|03:59

Health Ministry calls on Israelis to get vaccinated as measles cases surge 18 cases diagnosed in Israel In past three months, majority not fully vaccinated; ministry recommends travelers abroad ensure they are vaccinated with two doses https://www.ynetnews.com/health_science/article/rjchvwfip Adir Yanko|03:59

Fernando and Louis lost a lot of weight in captivity: Here's how you come back from malnutrition For 129 days, freed hostages faced hunger, surviving on pita and white cheese; dietitians warn of risks from rapid weight loss, advising careful nutritional rehabilitation; 'You have to return them to nutrition very carefully' Ron Crissy|08:53

Fernando and Louis lost a lot of weight in captivity: Here's how you come back from malnutrition For 129 days, freed hostages faced hunger, surviving on pita and white cheese; dietitians warn of risks from rapid weight loss, advising careful nutritional rehabilitation; 'You have to return them to nutrition very carefully' Ron Crissy|08:53 https://www.ynetnews.com/health_science/article/s1yx8m5st

The dangerous bacterium that killed an IDF soldier Meningococcus is a bacterium that can cause serious and life-threatening disease but manifest via symptoms usually not paid attention to by individuals Dr. David Shasha|Yesterday | 04:50

The dangerous bacterium that killed an IDF soldier Meningococcus is a bacterium that can cause serious and life-threatening disease but manifest via symptoms usually not paid attention to by individuals Dr. David Shasha|Yesterday | 04:50 https://www.ynetnews.com/health_science/article/hkoe7fosp

lunes, 12 de febrero de 2024

A response to your 3 Feb post regarding red-light therapy for myopia

Dear Editor of the Salud Equitativa blog, On the 3rd of February you reposted an article from STAT News about red-light therapy for the treatment of myopia. My client is the manufacturer of the only red-light therapy device to be licensed and approved for the treatment of myopia in mor than 30 countries around the world. As such we would appreciate an opportunity to rebut some of the inaccurate statements made by Dr. Ostrin in that article. I hope you will consider posting our letter of response below. Dear Editor, Eyerising International would appreciate an opportunity to respond to, and rebut certain claims made in, an article you posted on 3rf February under the headline, “Promising red-light myopia treatment for children is raising safety concerns among experts Annalisa Merelli By Annalisa Merelli Feb. 2, 2024” The piece was reporting on an article recently published in the Ophthalmic & Physiological Optics (OPO) Journal, titled, “Red light instruments for myopia exceed safety limits”, which was authored by Lisa A. Ostrin and Alexander W. Schill. Eyerising International has spoken to the Editor-in-Chief of the OPO Journal, and he has agreed to give the company the right of reply to Dr Ostrin’s article and to publish a letter to the editor addressing several of the inaccuracies and misrepresentations in Dr Ostrin’s OPO article. As the originator of repeat low-level, red light therapy (RLRL) sometimes also called LLRL (low level red light therapy) and the manufacturer of the only red-light myopia management device licensed and approved for the treatment of myopia in multiple countries, Eyerising International would like to address some inaccuracies Dr Ostrin repeated in your article. Point 1 In the press release, based on only testing two copycat devices in her laboratory Dr Ostrin generalises to all red light devices: “The safety profiles of red-light laser devices for myopia have not been fully investigated,” The Eyerising device has been very fully investigated, it has undergone 10 clinical trials and four (4) real world studies, covering 1785 patients, with a cumulative clinical trial use of 9.25 years - with zero significant adverse events recorded. The device has been used to treat more than 160,000 patients in the real world over the past eight years, and there are currently more than 80,000 daily users. To date, there have only been five (5) cases of significant adverse side effects reported; with no permanent damage recorded. Point 2 In the press release Dr Ostrin said: “Based on measurements in our laboratory, it is recommended that clinicians strongly reconsider the use of LLRL therapy for myopia in children until safety standards can be confirmed,” Numerous countries have established such safety standards and unlike the two copycat devices Dr Ostrin tested in her laboratory the Eyerising device meets the quality, safety, and efficacy standards required by medical regulators in over 30 countries across Europe and APAC, with several more pending. 1. Eyerising International is ISO 13485:2016 certified by notified body BSI. 2. CE mark as Class IIa medical device 3. MHRA approved Class IIa in UK 4. MedSafe Class IIa in New Zealand 5. TMMDA approved Class IIa in Turkey 6. Australian Register of Therapeutic Goods (ARTG) in Australia 7. Medical Device Authority (MDA) in Malaysia Point 3 Testing to the wrong standards Dr Ostrin and her colleague stated in the original OPO article that they tested two devices to the ANSI Z136.1 standard as the benchmark for their tests. Although they acknowledged that the ANSI Z136.1 standards were developed to protect individuals from accidental exposure to lasers in occupational situations, they did not mention that there is a more recent ANSI standard specifically for ophthalmic instruments. The ANSI Z80.36 standard specifies fundamental requirements for optical radiation safety for ophthalmic instruments. It applies to all ophthalmic instruments (including current, new, and emerging instruments) that direct optical radiation into, or at the eye. It also applies to those parts of therapeutic or surgical systems that direct optical radiation into, or at the eye for diagnostic, illumination, measurement, imaging, or alignment purposes [2]. It is the ANSI Z80.36-2021 standard, which the FDA required Eyerising to meet and which we obtained. Point 4 In the article you ran Dr Ostrin said: “The company behind one of the devices reports that it is already being used to address myopia in over 100,000 pediatric patients.” As Eyerising International is the only company with an approved product this can only refer to us, although it fails to mention that the Eyerising device has a proven safety record in both clinical trial and real-world settings. The Eyerising device has to be prescribed by an Eye Health professional such as an ophthalmologist or optometrist. It has been used to treat more than 160,000 patients with only five (5) cases of significant adverse side effects reported. Eyerising International is not just the leading player in the field of LLRL but the only player in the field with a red light device licensed and approved by regulatory authorities in multiple countries for the treatment of myopia. Despite that obvious qualification Dr Ostrin never tested our device and never even requested one of our devices to test. Had she done so we would have been happy to supply one as we have every confidence in its safety record. Despite never testing our device Dr Ostrin referred to it inaccurately several time in her OPO article and by implication by generalising her comments to cover all red light devices for treating myopia, although she only tested two. In conclusion: Eyerising International takes our responsibility for ensuring the safety and efficacy of our RLRL therapy device seriously. We remain committed to working closely with healthcare professionals and users to collect and investigate any adverse reactions and to address any potential concerns. Apart from our extensive and on-going clinical trials we always consult the relevant authorities when entering new markets to ensure that our device meets any and all safety standards required by the relevant authorities. About Eyerising International Eyerising International is an Australian MedTech company developing life-impacting eye-health therapy to slow the progression of myopia. We are led by a team of world-renowned ophthalmology academics, researchers and a board with a proven track record in MedTech innovation, implementation, and clinical facilitation. Eyerising International’s patented Myopia Management Repeated Low-Level Red–Light (RLRL) therapy was conceived and developed by ERI’s Chief Medical Officer, Professor Mingguang He, a global leader in myopia control and the development of artificial intelligence systems in ophthalmology. This innovation in childhood myopia control meets the quality, safety, and efficacy standards required by medical regulators in over 30 countries across Europe and Australasia. Issued by: Eyerising International Pty Ltd 2.05 9/11 Claremont St, South Yarra VIC 3141, Australia PR@eyerisinginternational.com References: Lisa A. Ostrin and Alexander W. Schill. “Red light instruments for myopia exceed safety limits”, OPO January 2024. ANSI Z80.36-2016 Tian Yu, Xiao Zhigang, Recovery of retinal structural damage after repeated low-intensity red light therapy for high myopia: a case report, CMA.J.CN, August 2023 - https://rs.yiigle.com/cmaid/1471399 John Battersby Senior Regional Account Director Bridges M&C Pte Ltd (HQ) | 176 Joo Chiat Road #04-01 Singapore 427447 D: +65 6345 1783 | M: +65 9754 1092 | E: john@bridges-comms.com

Global launch of The Lancet Gastroenterology & Hepatology Commission on viral hepatitis Feb 15, 2024 13:00 GMT / 08:00 EST

https://www.thelancet.com/webinars?dgcid=hubspot_email_conferencealerts_isc24&utm_campaign=conferencealerts&utm_medium=email&_hsmi=293282980&_hsenc=p2ANqtz--aTBO399nIs4aDm_gk4ymo0IciXKUsydWJbsH6YV7LWNF898NZfj5iKBCf6q5d4iwXQv6brDqvgnV1xKCLtsMnE37nqg&utm_content=293282980&utm_source=hs_email Globally more than 300 million individuals are living with hepatitis B or C. Deaths and disability caused by the long-term complications of these chronic infections represent a major public health challenge. In 2016, the WHO set ambitious goals to eliminate viral hepatitis by 2030. Join authors for the global launch of the new Lancet Gastroenterology & Hepatology Commission on viral hepatitis, exploring global and regional progress towards the elimination of this disease.

viernes, 9 de febrero de 2024

SWEET POISON? NOT SO SWEET SIDE OF ARTIFICIAL SWEETENERS

Sweet Poison? Not So Sweet Side of Artificial Sweeteners By Ivanhoe Broadcast News on February 17, 2024 https://www.ivanhoe.com/?p=32465&preview=1&_ppp=9bd2ee2376

IMPLANTABLE STIMULATORS: SPARKING LIFE INTO FAILING HEARTS

Implantable Stimulators: Sparking Life into Failing Hearts By Ivanhoe Broadcast News on February 13, 2024 https://www.ivanhoe.com/?p=32486&preview=1&_ppp=aec85c108b

Health care or housing? More states are using Medicaid funds to help the homeless While some see the move as ‘innovative and practical,’ others call the practice a ‘huge money drain’ Melissa Rudy By Melissa Rudy Fox News Published February 6, 2024 4:30am EST

Health care or housing? More states are using Medicaid funds to help the homeless While some see the move as ‘innovative and practical,’ others call the practice a ‘huge money drain’ Melissa Rudy By Melissa Rudy Fox News Published February 6, 2024 4:30am EST https://www.foxnews.com/health/health-care-housing-more-states-using-medicaid-funds-help-homeless

Music could be the secret to fighting off dementia, study says: ‘Profound impact’ People who played instruments or sang could have stronger memory and cognitive function, researchers found Melissa Rudy By Melissa Rudy Fox News Published February 2, 2024 5:30am EST

Music could be the secret to fighting off dementia, study says: ‘Profound impact’ People who played instruments or sang could have stronger memory and cognitive function, researchers found Melissa Rudy By Melissa Rudy Fox News Published February 2, 2024 5:30am EST https://www.foxnews.com/health/music-could-be-secret-fighting-dementia-study-profound-impact

6 surprisingly simple ways to keep yourself healthy (hint: sleep is involved) Go 'back to the basics' for good health, physician at The Ohio State University Wexner Medical Center recommends Melissa Rudy By Melissa Rudy Fox News Published February 7, 2024 5:00am EST

6 surprisingly simple ways to keep yourself healthy (hint: sleep is involved) Go 'back to the basics' for good health, physician at The Ohio State University Wexner Medical Center recommends Melissa Rudy By Melissa Rudy Fox News Published February 7, 2024 5:00am EST https://www.foxnews.com/health/6-surprisingly-simple-ways-keep-yourself-healthy-hint-sleep-involved

Ask a doc: ‘Why are my ears ringing, and should I see a doctor?’ Here are the symptoms, causes, treatments and prevention ideas for tinnitus, which affects millions of people Melissa Rudy By Melissa Rudy Fox News Published February 7, 2024 10:21am EST

Ask a doc: ‘Why are my ears ringing, and should I see a doctor?’ Here are the symptoms, causes, treatments and prevention ideas for tinnitus, which affects millions of people Melissa Rudy By Melissa Rudy Fox News Published February 7, 2024 10:21am EST https://www.foxnews.com/health/ask-doc-why-ears-ringing-should-see-doctor

NIH Toolbox® Assessments Conference Dates April 8, 2024 | 8:30 a.m. – 5:30 p.m. April 9, 2024 | 8:30 a.m. – 1:00 p.m.

https://www.nia.nih.gov/nih-toolbox-conference?utm_source=NIA+Main&utm_campaign=758321e978-blog-subemail-CASToolbox-2-7-24&utm_medium=email&utm_term=0_-8180ce9847-%5BLIST_EMAIL_ID%5D NIH Toolbox® Assessments Conference, April 8-9: NIA, along with the NIH Blueprint for Neuroscience Research, National Institute of Neurological Disorders and Stroke, and Eunice Kennedy Shriver National Institute of Child Health and Human Development, will host a conference on NIH-funded neurological and behavioral measures and measurement systems. We invite the NIH community, extramural investigators, clinicians, and other stakeholders to join us in person in Bethesda or virtually to learn about recent updates, improvements, and adaptations to the NIH Toolbox®, the NIH Infant and Toddler Toolbox (NIH Baby Toolbox), Mobile Toolbox, and MyCog.

Cognitive Aging Summit IV Dates March 20, 2024 - March 21, 2024

https://www.nia.nih.gov/research/dn/cognitive-aging-summit-iv?utm_source=NIA+Main&utm_campaign=758321e978-blog-subemail-CASToolbox-2-7-24&utm_medium=email&utm_term=0_-8180ce9847-%5BLIST_EMAIL_ID%5D Cognitive Aging Summit IV, March 20-21: Join NIA and the McKnight Brain Research Foundation to explore new frontiers in the science of age-related brain and cognitive change. The summit will be held in-person in Bethesda, Maryland, and focus on individual differences and personalized approaches for remediating cognitive decline and maintaining cognitive health.

No Glucose? Pancreatic Cancer May Have a Ready Energy Alternative ++++

No Glucose? Pancreatic Cancer May Have a Ready Energy Alternative A new study finds that pancreatic cancer cells have a ready way to overcome a lack of glucose, a frequent occurrence in this disease. They use another fuel source: a molecule called uridine. Findings from a related study suggest other cancers do as well. https://www.cancer.gov/news-events/cancer-currents-blog/2023/pancreatic-cancer-uridine-energy-alternative?cid=eb_govdel How Some Brain Tumors Hijack the Mind to Grow Researchers have found that the aggressive brain cancer glioblastoma can co-opt the formation of new synapses to fuel its own growth. This neural redirection also appears to play a role in the devastating cognitive decline seen in many people with glioblastoma. https://www.cancer.gov/news-events/cancer-currents-blog/2023/glioblastoma-hijacks-neuroplasticity-tsp-1?cid=eb_govdel Coming Full Circle on Cancer and Extrachromosomal DNA A new study shows for the first time that a circular form of DNA, called ecDNA, is present in precancerous tissue and not just cancer cells. The study also suggested that when ecDNA is present in Barrett’s esophagus, that tissue is almost certain to become cancer. https://www.cancer.gov/news-events/cancer-currents-blog/2023/extrachromosomal-dna-barretts-esophageal-cancer?cid=eb_govdel Vulnerability in Brain Tumors May Open Door to New Treatments Two companion studies have found different forms of some brain tumors, diffuse midline glioma and IDH-mutant glioma, become dependent for their survival on the production of chemicals called pyrimidines. Researchers are planning clinical trials to test a drug that blocks pyrimidine synthesis in patients with gliomas. https://www.cancer.gov/news-events/cancer-currents-blog/2022/glioma-treatment-targeting-pyrimidine-synthesis?cid=eb_govdel

Global launch of The Lancet Gastroenterology & Hepatology Commission on viral hepatitis Feb 15, 2024 13:00 GMT / 08:00 EST

https://www.thelancet.com/webinars?dgcid=hubspot_email_update_feature_lancetwebinars_landig&utm_campaign=update-landig&utm_medium=email&_hsmi=292995656&_hsenc=p2ANqtz--InKpEf7ss7tPahNkLc-OiAwSf3F9T6JcgKcvtUY0e7t8ENjOoxU6wfTLG-9pPOuRKsMto9ZaAMIVHNGxRa42wNRIWhw&utm_content=292924864&utm_source=hs_email Globally more than 300 million individuals are living with hepatitis B or C. Deaths and disability caused by the long-term complications of these chronic infections represent a major public health challenge. In 2016, the WHO set ambitious goals to eliminate viral hepatitis by 2030. Join authors for the global launch of the new Lancet Gastroenterology & Hepatology Commission on viral hepatitis, exploring global and regional progress towards the elimination of this disease.

Maximizing scarce colonoscopy resources: the crucial role of Stool-Based tests

https://pubmed.ncbi.nlm.nih.gov/38310359/ From the abstract: "During the COVID-19 pandemic, health systems, including federally qualified health centers (FQHCs), experienced disruptions in colorectal cancer (CRC) screening. National organizations called for greater use of at-home stool-based testing followed by colonoscopy for those with abnormal test results to limit (in-person) colonoscopy exams to people with acute symptoms, or who were high-risk. This ‘stool-test-first’ strategy may also be useful for adults with low-risk adenomas who are due for surveillance colonoscopy. "

domingo, 4 de febrero de 2024

Forget lung, breast or prostate cancer: why tumour naming needs to change The conventional way of classifying metastatic cancers according to their organ of origin is denying people access to drugs that could help them. F Andre et al, Nature, January 31, 2024

https://phgkb.cdc.gov/PHGKB/phgHome.action?action=archive&date=02/01/2024 From the article: " Over the past century, the two main approaches to treating people with cancer — surgery and radiation — have focused on where in the body the tumour is. This has led to medical oncologists and other health-care providers, regulatory agencies, insurance companies, drug firms — and patients — categorizing cancers according to the organ in which the tumour originated. Yet there is a growing disconnect between classifying cancers in this way and developments in precision oncology, which uses the molecular profiling of tumour and immune cells to guide therapies."

Heart Disease Risk Higher with Genetic Variant Plus Even Slightly Elevated Cholesterol Inside Precision Medicine, February 2, 2023

https://phgkb.cdc.gov/PHGKB/phgHome.action?action=all%20hot%20topics From the article: " Even people with moderately elevated low-density lipoprotein cholesterol (LDL-C) have higher risk of heart disease if they also had a variant for familial hypercholesterolemia (FH), according to new research. The long-term study included over 20,000 patients and reinforces the value of genetic testing for this condition."